Sunday, November 10, 2013
Equity Research: NXT-ID (OTCQB:NXTD) Mobile-Bio Platform Enables M-Commerce
Equity Research: NXT-ID (OTCQB:NXTD) Mobile-Bio Platform Enables M-Commerce
(Investorideas.com biometrics/ defense stocks newswire) SeekingAlpha.com: SoundView Technology Group issues equity research note - NXT-ID (OTCQB: NXTD) Mobile-Bio Platform Enables M-Commerce.
Technology is finally enabling bio-based security features on mobile devices that will overcome one of the final obstacles to truly mobile digital commerce. One company, NXT-ID (OTC:NXTD), has emerged as a newly public company with a set of technologies and an open platform that can be used across all these applications. Based on our analysis the next few quarters of adoption will drive a near-term intrinsic value of over $10/share and a much higher figure for 2014. This report goes into more detail concerning the technology, the market, and the company.
full article
http://seekingalpha.com/article/1810572-nxt-id-mobile-bio-platform-enables-m-commerce?source=yahoo
Monday, October 28, 2013
Mobile biometric security products and services is set to grow and will generate over $8.3 billion revenue by 2018
Biometrics Research; Goode Intelligence forecasts that the market for mobile biometric security products and services is set to grow and will generate over $8.3 billion revenue by 2018
The leading company in mobile security analysis, Goode Intelligence, has published a new market forecast report covering the mobile biometric security market which, driven by Apple's positive move with Touch ID, forecasts exceptional growth for the industry.
full article
http://www.investorideas.com/news/2013/biometrics/10281.asp
Research Biometric stocks at Investorideas.com stock directory
http://www.investorideas.com/BPS/Stock_List.asp
Published at (www.investorideas.com defense stocks blog )
Research defense and Homeland Security stocks with the largest global defense stocks directory online for investors at Investorideas.com and www.Homelanddefensestocks.com click here: http://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp
Defense and security companies - Become a showcase defense stock at www.investorideas.com and www.homelanddefensestocks.com for as little as $1000 month
Tuesday, September 3, 2013
Merger potential in European aerospace
September 3, 2013 (www.investorideas.com newswire) Over the past 50
years, the trends in the aerospace industry have been clear – from the
gradual amalgamation of the US industry into the twin giants of Boeing
and Lockheed Martin, to the creation of consolidated manufacturers such
as MBDA, makers of missile technology for air forces and armies across
the world, aerospace is rapidly becoming a smaller, more concentrated
industry.
Take EADS, for example. Beginning as a merger of German-based
DaimlerChrysler Aerospace (DASA), the Spanish Construcciones
Aeronáuticas and France's Aérospatiale-Matra, it's grown to become one
of the biggest aerospace companies in the world, building anything from
Eurocopter helicopters, to Airbus super-jumbos, to space capsules that
resupply the International Space Station.
It trades across six European stock exchanges and recently reported a very healthy 21% rise in earnings, with more to come as its advanced Airbus A380 superjumbos and A400M transport aircraft continue to be delivered. But EADS faces a stiff competitor in the form of British-based BAE Systems.
From its roots as British Aerospace, BAE Systems has grown to become a huge multinational corporation, and ironically, considering its roots, now is a bigger supplier to the US military than the UK. Thanks to a long standing atmosphere of co-operation between the UK and US governments, BAE Systems faces a smoother ride when working with the US military compared to its European rival. This has helped it become a primary supplier in a range of fields from electronic warfare components for the US Air Force's most advanced jet fighters to armoured vehicles for the Army - just recently, it won another £500m contract.
BAE Systems has often bucked the trend of a dismal trading day on the FTSE by boosting its shares, including a rise from a 2009 contract for torpedoes used by the Royal Navy and Royal Air force that also saw shares in insurance giant Catlin Insurance UK rise positively.
What lies in the future for Europe's aerospace industry? EADS and BAE Systems worked together closely on the manufacturer of the brand-new Eurofighter over its multi-decade development process. In late 2012, rumours circulated that they were considering a merger in which BAE shareholders would end up with 40% of the new company and EADS shareholders 60%.
A combined EADS and BAE Systems would be a gigantic aerospace company - the biggest in the world, in fact, with $93 billion in sales compared to Boeing's $68.7 billion. But it seems unlikely to happen, due to a lack of political will. Despite long discussions between the British, French and German governments, there just wasn't enough common ground for politicians to agree to a merger. The UK government sought to protect BAE Systems' strong business ties to the Pentagon and the US Department of Defense by restricting any political influence the three governments could have over the combined company. Yet the German representatives were opposed to the entire deal on fundamental grounds. It remains to be seen what the hopes for a EADS/BAE merger will be in the future, but it will take a large change in the political atmosphere to be feasible.
Source Jake Redknapp
Contact jake.redknapp@gmail.com
It trades across six European stock exchanges and recently reported a very healthy 21% rise in earnings, with more to come as its advanced Airbus A380 superjumbos and A400M transport aircraft continue to be delivered. But EADS faces a stiff competitor in the form of British-based BAE Systems.
From its roots as British Aerospace, BAE Systems has grown to become a huge multinational corporation, and ironically, considering its roots, now is a bigger supplier to the US military than the UK. Thanks to a long standing atmosphere of co-operation between the UK and US governments, BAE Systems faces a smoother ride when working with the US military compared to its European rival. This has helped it become a primary supplier in a range of fields from electronic warfare components for the US Air Force's most advanced jet fighters to armoured vehicles for the Army - just recently, it won another £500m contract.
BAE Systems has often bucked the trend of a dismal trading day on the FTSE by boosting its shares, including a rise from a 2009 contract for torpedoes used by the Royal Navy and Royal Air force that also saw shares in insurance giant Catlin Insurance UK rise positively.
What lies in the future for Europe's aerospace industry? EADS and BAE Systems worked together closely on the manufacturer of the brand-new Eurofighter over its multi-decade development process. In late 2012, rumours circulated that they were considering a merger in which BAE shareholders would end up with 40% of the new company and EADS shareholders 60%.
A combined EADS and BAE Systems would be a gigantic aerospace company - the biggest in the world, in fact, with $93 billion in sales compared to Boeing's $68.7 billion. But it seems unlikely to happen, due to a lack of political will. Despite long discussions between the British, French and German governments, there just wasn't enough common ground for politicians to agree to a merger. The UK government sought to protect BAE Systems' strong business ties to the Pentagon and the US Department of Defense by restricting any political influence the three governments could have over the combined company. Yet the German representatives were opposed to the entire deal on fundamental grounds. It remains to be seen what the hopes for a EADS/BAE merger will be in the future, but it will take a large change in the political atmosphere to be feasible.
Source Jake Redknapp
Contact jake.redknapp@gmail.com
Wednesday, August 28, 2013
Biometrics/ Mobile Security Stock Investor Alert (OTCQB: NXTD): Information Available Through S&P Capital IQ Corporation Records Program for Biometric Company NXT-ID, Inc.
Shelton, CT - August 28, 2013 (Investorideas.com biometrics/ defense stocks newswire) NXT-ID, Inc. (OTCQB:NXTD)
a biometrics company focused on the growing m-commerce market announces
today that its company information would be made available via S&P
Capital IQ Corporation Records Listing Program. As part of the program, a
full description of NXT-ID, Inc. will be published in the Daily News
Section of Standard & Poors's Corporation Records, a recognized
securities manual for secondary trading in up to 38 States under the
Blue Sky Laws. S&P Capital IQ Corporation Records is available in
print, CD-ROM, and via the web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.
The company information about NXT-ID, Inc. to be made available
through this program includes an in-depth description of the company's
business operations, share price, dividend history, shares outstanding,
company financial position, earnings, and full income statement and
balance sheet.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
About S&P Capital IQ
S&P Capital IQ, a part of McGraw Hill Financial, is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities
around the world. Evaluated pricing is prepared by Standard &
Poor's Securities Evaluations, Inc., a part of S&P Capital IQ and a
registered investment adviser with the U.S. Securities and Exchange
Commission. In the United States, research reports are prepared by
Standard & Poor's Investment Advisory Services LLC, a part of
S&P Capital IQ and a registered investment adviser with the U.S.
Securities and Exchange Commission. S&P Capital IQ provides a broad
suite of capabilities designed to help track performance, generate
alpha, and identify new trading and investment ideas, and perform risk
analysis and mitigation strategies. Through leading desktop solutions
such as the S&P Capital IQ, Global Credit Portal and MarketScope
Advisor desktops; enterprise solutions such as S&P Capital IQ
Valuations; and research offerings, including Leveraged Commentary &
Data, Global Markets Intelligence, and company and funds research,
S&P Capital IQ sharpens financial intelligence into the wisdom
today's investors need. For more information visit: www.spcapitaliq.com
Company information distributed through the Corporation Records Program is based upon information that S&P Capital IQ considers to be reliable, but neither S&P Capital IQ nor its affiliates warrant its completeness or accuracy, and it should not be relied upon as such. This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument.
Contact:
Corporate info: info@nxt-id.com
Investor Relations
Jared Mitchell
Managing Director
ProActive Capital
www.ProActiveCapital.com
Direct: 646.863.6274
Cell: 917.453.0637
jmitchell@proactivecapital.com
S&P Capital IQ Customer Contact:
Richard Albanese
212 438-3647
S&P Capital IQ Media Relations
Michael Privitera
212 438-6679
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: this release was compensated for by NXTD as part of a monthly service for news publication and distribution and content marketing. (five thousand per month plus 144 shares)
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
About S&P Capital IQ
S&P Capital IQ, a part of McGraw Hill Financial, is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities
around the world. Evaluated pricing is prepared by Standard &
Poor's Securities Evaluations, Inc., a part of S&P Capital IQ and a
registered investment adviser with the U.S. Securities and Exchange
Commission. In the United States, research reports are prepared by
Standard & Poor's Investment Advisory Services LLC, a part of
S&P Capital IQ and a registered investment adviser with the U.S.
Securities and Exchange Commission. S&P Capital IQ provides a broad
suite of capabilities designed to help track performance, generate
alpha, and identify new trading and investment ideas, and perform risk
analysis and mitigation strategies. Through leading desktop solutions
such as the S&P Capital IQ, Global Credit Portal and MarketScope
Advisor desktops; enterprise solutions such as S&P Capital IQ
Valuations; and research offerings, including Leveraged Commentary &
Data, Global Markets Intelligence, and company and funds research,
S&P Capital IQ sharpens financial intelligence into the wisdom
today's investors need. For more information visit: www.spcapitaliq.comCompany information distributed through the Corporation Records Program is based upon information that S&P Capital IQ considers to be reliable, but neither S&P Capital IQ nor its affiliates warrant its completeness or accuracy, and it should not be relied upon as such. This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument.
Contact:
Corporate info: info@nxt-id.com
Investor Relations
Jared Mitchell
Managing Director
ProActive Capital
www.ProActiveCapital.com
Direct: 646.863.6274
Cell: 917.453.0637
jmitchell@proactivecapital.com
S&P Capital IQ Customer Contact:
Richard Albanese
212 438-3647
S&P Capital IQ Media Relations
Michael Privitera
212 438-6679
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: this release was compensated for by NXTD as part of a monthly service for news publication and distribution and content marketing. (five thousand per month plus 144 shares)
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Friday, August 23, 2013
Biometric/ Mobile Security Stock NXT-ID, Inc. (OTCQB:NXTD) Launches Pilot Program for Palm Bay , FL Police Department
Shelton, CT - August 23, 2013 (Investorideas.com mobile payment stocks newswire) NXT-ID, Inc. (OTCQB:NXTD),
a biometrics company focused on the growing m-commerce market announces
that its wholly owned subsidiary, 3D-ID, LLC commenced a pilot program
with the Palm Bay, FL Police Department to evaluate its 3D FaceMatch™
biometric facial recognition identification systems.
The identification management systems leverage unique and patented
FaceMatch™ 3D technology that precisely senses shape at up to a million
points on a face without using lasers or projected patterns. This
individually unique shape information is compressed into a small 3D
biometric template containing a complete 3D shape signature of that
individual face. This shape signature is rapidly compared to other
templates in a database. Unlike 2D recognition methods where performance
is highly variable depending on scene lighting, head pose, facial
expression, eyewear, facial hair and cosmetics, FaceMatch™ templates and
performance remains invariant over an extremely wide range of imaging
variables. This enables reliable, scalable, and convenient face
recognition solutions.
The system is being used at Palm Bay to enroll inmates into local detention centers, creating a 3- dimensional database that can be used in the future to potentially identify persons of interest. Inmates that are released will also have their identities verified through 3D facial recognition to prevent the inadvertent release of the wrong individual.
The pilot program is expected to expand to include more law enforcement agencies connected to 3D-ID's BioCloud™ to improve identification of previously enrolled (booked) individuals from multiple law enforcement agencies searching from a common 3D database. Further expansion is expected to include capture of faces from surveillance cameras, video, and from mobile devices using 3D-ID's MobileBio™ technologies under development.
John Blackledge, Deputy Chief of the Palm Bay Police Department, said, "3D facial recognition is an important technology innovation that will give law enforcement the upper hand in accurately and rapidly identify criminals. 3D-ID provides a new technology platform that allows law enforcement to make positive identification without the intrusiveness of conventional police methods."
Doug Muldoon, Palm Bay Police Chief, FBI-NA President, noted, "Our partnership with NXT-ID in 3D facial recognition is yet another opportunity to become more efficient and effective in fighting crime."
NXT-ID is a leader in biometric-based identity management and access control systems. Its product line offers cost-effective solutions for facilities access and control, inmate population management, identity management and border control. NXT-ID advanced biometric tools achieve excellent facial recognition performance using 3D camera technology, along with advanced 2D-to-3D conversion algorithms, and sketching systems that significantly simplify composite sketching with powerful 3D morphing technology.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID’ wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Relations
Jared Mitchell
Managing Director
ProActive Capital
www.ProActiveCapital.com
Direct: 646.863.6274
Cell: 917.453.0637
jmitchell@proactivecapital.com
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: this release was compensated for by NXTD as part of a monthly service for news publication and distribution and content marketing. (five thousand per month plus 144 shares)
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
The system is being used at Palm Bay to enroll inmates into local detention centers, creating a 3- dimensional database that can be used in the future to potentially identify persons of interest. Inmates that are released will also have their identities verified through 3D facial recognition to prevent the inadvertent release of the wrong individual.
The pilot program is expected to expand to include more law enforcement agencies connected to 3D-ID's BioCloud™ to improve identification of previously enrolled (booked) individuals from multiple law enforcement agencies searching from a common 3D database. Further expansion is expected to include capture of faces from surveillance cameras, video, and from mobile devices using 3D-ID's MobileBio™ technologies under development.
John Blackledge, Deputy Chief of the Palm Bay Police Department, said, "3D facial recognition is an important technology innovation that will give law enforcement the upper hand in accurately and rapidly identify criminals. 3D-ID provides a new technology platform that allows law enforcement to make positive identification without the intrusiveness of conventional police methods."
Doug Muldoon, Palm Bay Police Chief, FBI-NA President, noted, "Our partnership with NXT-ID in 3D facial recognition is yet another opportunity to become more efficient and effective in fighting crime."
NXT-ID is a leader in biometric-based identity management and access control systems. Its product line offers cost-effective solutions for facilities access and control, inmate population management, identity management and border control. NXT-ID advanced biometric tools achieve excellent facial recognition performance using 3D camera technology, along with advanced 2D-to-3D conversion algorithms, and sketching systems that significantly simplify composite sketching with powerful 3D morphing technology.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID’ wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Corporate info: info@nxt-id.com
Investor Relations
Jared Mitchell
Managing Director
ProActive Capital
www.ProActiveCapital.com
Direct: 646.863.6274
Cell: 917.453.0637
jmitchell@proactivecapital.com
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: this release was compensated for by NXTD as part of a monthly service for news publication and distribution and content marketing. (five thousand per month plus 144 shares)
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Monday, June 10, 2013
Marijuana Vending Machines Race: Marijuana Stocks to Watch (ERBB), (HSCC), (MDBX)
Point Roberts, WA/ New York, NY - June 10, 2013 (Investorideas.com
Newswire) Investorideas.com staff: Investorideas.com, an investor
research portal specializing in sector research for independent
investors reports on Marijuana stocks in the race for Marijuana vending
machines.
According to an article today in the DailyMail in article entitled, “Marijuana vending machines coming to a store near you?”Entrepreneurs
are looking to cash in on the marijuana vending machine market in
Colorado and Washington State, where marijuana was recently legalized.
Retail sales are expected to start in Colorado by January 2014 with
Washington State following shortly after.
Several public companies have entered the space, including Medbox Inc., (OTC: MDBX) , Tranzbyte Corporation (ERBB OTC Markets) and Homeland Security Corporation (HSCC:OTC Markets) . Medbox and Tranzbyte are further ahead in development, with Medbox having a patent on their design that uses biometrics but Homeland Security Corporation is also betting on the added value of their biometric security technology.
Homeland Security Corporation (HSCC: OTC Markets) notes on its new website,
“We are first and foremost a security and surveillance organization. One of our evolving goals is to be the premier MMJ/MJ compliance and security systems innovator for the cannabis and hemp industry, leveraging our team of highly experienced, educated, and seasoned professionals. The MMJ industry is one of the most scrutinized industries in the world. From seed to sale all aspects of the MMJ industry including growers, producers, and dispensaries are under twenty-four hour recorded surveillance.”
The company also goes on to say, “Over the past three years our HSCC representative (Gary Williams) was based in Colorado working directly with a leading MMJ compliance organization, the Colorado Medical Marijuana Enforcement Division (MMED), and also with other state regulatory agencies.” More info: http://www.hsccsecurity.com/MMJ-Consulting.html
Medbox Inc., (OTC: MDBX), the leader so far, features patented systems that dispense medication to individuals based on biometric identification (fingerprint sample). The stock has had a wild ride for an OTC stock as investors bet on the future of legalized Marijuana and the future of vending machines.
Tranzbyte Corporation (ERBB OTC Markets)
announced in April it will begin distribution of its Automated
Marijuana Vending Machine within qualifying states and locales beginning
next quarter. Although some of the specific details of the machine's
operation must be kept under wraps for competitive reasons, the company
has been at work for the past year identifying and working with a
vending machine manufacturer that has the technological background and
capability to exclusively deliver the Altitude Organix "Green Machine" –
designed specifically to serve the exploding cannabis industry in the
21st Century with a complement of exclusively available Zazzz™ products
coupled with state-of-the-art security enhancements.
Article source: http://www.dailymail.co.uk/news/ article-2338726/ Marijuana- vending-machines-coming -store-near-you.html? ito=feeds-newsxml
About InvestorIdeas.com:
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more. The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
Or …
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products. Investorideas does not provide broker deal or investor relations services or securities. http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas is compensated by HSCC in restricted 144 shares in exchange for services including news distribution: full details: http://www.investorideas.com/About/News/Clientspecifics.asp
This site is currently compensated by featured companies, news submissions and online advertising. Investorideas was not compensated for this content.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
Several public companies have entered the space, including Medbox Inc., (OTC: MDBX) , Tranzbyte Corporation (ERBB OTC Markets) and Homeland Security Corporation (HSCC:OTC Markets) . Medbox and Tranzbyte are further ahead in development, with Medbox having a patent on their design that uses biometrics but Homeland Security Corporation is also betting on the added value of their biometric security technology.
Homeland Security Corporation (HSCC: OTC Markets) notes on its new website,
“We are first and foremost a security and surveillance organization. One of our evolving goals is to be the premier MMJ/MJ compliance and security systems innovator for the cannabis and hemp industry, leveraging our team of highly experienced, educated, and seasoned professionals. The MMJ industry is one of the most scrutinized industries in the world. From seed to sale all aspects of the MMJ industry including growers, producers, and dispensaries are under twenty-four hour recorded surveillance.”
The company also goes on to say, “Over the past three years our HSCC representative (Gary Williams) was based in Colorado working directly with a leading MMJ compliance organization, the Colorado Medical Marijuana Enforcement Division (MMED), and also with other state regulatory agencies.” More info: http://www.hsccsecurity.com/MMJ-Consulting.html
Medbox Inc., (OTC: MDBX), the leader so far, features patented systems that dispense medication to individuals based on biometric identification (fingerprint sample). The stock has had a wild ride for an OTC stock as investors bet on the future of legalized Marijuana and the future of vending machines.
Tranzbyte Corporation (ERBB OTC Markets)
announced in April it will begin distribution of its Automated
Marijuana Vending Machine within qualifying states and locales beginning
next quarter. Although some of the specific details of the machine's
operation must be kept under wraps for competitive reasons, the company
has been at work for the past year identifying and working with a
vending machine manufacturer that has the technological background and
capability to exclusively deliver the Altitude Organix "Green Machine" –
designed specifically to serve the exploding cannabis industry in the
21st Century with a complement of exclusively available Zazzz™ products
coupled with state-of-the-art security enhancements.
Article source: http://www.dailymail.co.uk/news/ article-2338726/ Marijuana- vending-machines-coming -store-near-you.html? ito=feeds-newsxmlAbout InvestorIdeas.com:
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more. The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
Or …
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products. Investorideas does not provide broker deal or investor relations services or securities. http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas is compensated by HSCC in restricted 144 shares in exchange for services including news distribution: full details: http://www.investorideas.com/About/News/Clientspecifics.asp
This site is currently compensated by featured companies, news submissions and online advertising. Investorideas was not compensated for this content.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
Thursday, June 6, 2013
Biodefense Stock Q&A; PositiveID (OTCBB: PSID) Chairman and CEO Discusses New Firefly Dx Detection System
Point Roberts, WA - June 6, 2013 (Investorideas.com Newswire)
Investorideas.com, a leader in research for independent investors
presents an exclusive Q&A interview with Mr. William J. Caragol,
Chairman and CEO of PositiveID Corporation (OTCBB: PSID)
discussing the recent launch of the development of the Firefly Dx
detection system. Firefly is a portable, hand-held, point-of-need
molecular diagnostic system, designed to provide test results from
sample input through reporting of results in less than 15 to 30 minutes
depending on the type of test performed.
Q: Investorideas.com
Firefly is based on technology from your M-BAND (Microfluidics-based Bioagent Networked Detector) airborne bio-threat detector; can you explain the evolution of this technology and what inspired it?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
Throughout meetings with past and potential new customers representing a variety of different industries, we listened to their needs and the circumstances they often face including military field deployments, evolving conditions in remote areas ,agricultural testing, etc and it became clear that there is a real and pressing need for portable, handheld, rapid biological testing solutions.
We have been able to evolve and miniaturize the patented technology advances we’ve achieved in the development of our M-BAND, which is basically a “lab-in-a-box,” and Dragonfly cartridge based systems to create a handheld, battery-powered, rapid biological testing system that can communicate test results from sample purification to final results in less than 30 minutes to a SMART phone or personal computer. Furthermore, the system is designed to be easy to use and does not require a high level of technical expertise to operate.
Q: Investorideas.com
According to your April 29, 2013 press release, Firefly is expected to quickly process human and agricultural samples to provide accurate confirmation of biological threats via a smart-phone application. What is a realistic time frame to see this app available to military in the field?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
The business strategy that we have employed for our biological detection technologies in the past and intend to continue moving forward is to innovate and develop novel technologies for markets in detection and diagnostics, and to partner with large firms that have a foothold in the market with scalable manufacturing capabilities. We believe that with the appropriate funding partner, we could complete the development of handheld prototypes and cartridges and have the devices ready for field testing in approximately 12 months.
Q: Investorideas.com
What biological agents can the Firefly Dx system detect?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
The assay format of the Firefly Dx is polymerase chain reaction (PCR) using Real-time TaqMan® probe-based chemistry and is currently adapted to detect both DNA and RNA targets. PositiveID is currently developing diagnostic panels for the Firefly Dx against measles, respiratory diseases, and Arboviral diseases. Because the Firefly Dx instrument is a universal cartridge-based system, however, it will be able to accommodate new assays or panels very rapidly. Some examples of organisms for which we have previously developed immunoassays include anthrax, small pox, various forms of influenza, and MRSA, among many others.
Q: Investorideas.com
Can you give us an update on your M-BAND system and the status of BioWatch Generation 3?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
As you know, on January 25, 2013, the U.S. Department of Homeland Security released a draft request for proposal (“RFP”) for Stage 1 of BioWatch Generation 3. At that time it was announced that the final RFP for Stage 1 would be released in the government’s third quarter of fiscal 2013, which ends June 30th. If that timeline holds, the RFP is expected to be awarded in late 2013 and have a performance period of 18 months. We look forward to the release of the final RFP and will keep our investors informed of any updates.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. http://www.PositiveIDCorp.com
About InvestorIdeas.com:
Investorideas.com is a meeting place for investors and public companies in leading sectors? Find investing ideas in biotech and biodefense stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global exchanges.
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed May 2013 for three months: $1500 plus 50,000 144 shares .
http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com: 800 665 0411
Firefly is based on technology from your M-BAND (Microfluidics-based Bioagent Networked Detector) airborne bio-threat detector; can you explain the evolution of this technology and what inspired it?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
Throughout meetings with past and potential new customers representing a variety of different industries, we listened to their needs and the circumstances they often face including military field deployments, evolving conditions in remote areas ,agricultural testing, etc and it became clear that there is a real and pressing need for portable, handheld, rapid biological testing solutions.
We have been able to evolve and miniaturize the patented technology advances we’ve achieved in the development of our M-BAND, which is basically a “lab-in-a-box,” and Dragonfly cartridge based systems to create a handheld, battery-powered, rapid biological testing system that can communicate test results from sample purification to final results in less than 30 minutes to a SMART phone or personal computer. Furthermore, the system is designed to be easy to use and does not require a high level of technical expertise to operate.
Q: Investorideas.com
According to your April 29, 2013 press release, Firefly is expected to quickly process human and agricultural samples to provide accurate confirmation of biological threats via a smart-phone application. What is a realistic time frame to see this app available to military in the field?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
The business strategy that we have employed for our biological detection technologies in the past and intend to continue moving forward is to innovate and develop novel technologies for markets in detection and diagnostics, and to partner with large firms that have a foothold in the market with scalable manufacturing capabilities. We believe that with the appropriate funding partner, we could complete the development of handheld prototypes and cartridges and have the devices ready for field testing in approximately 12 months.
Q: Investorideas.com
What biological agents can the Firefly Dx system detect?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
The assay format of the Firefly Dx is polymerase chain reaction (PCR) using Real-time TaqMan® probe-based chemistry and is currently adapted to detect both DNA and RNA targets. PositiveID is currently developing diagnostic panels for the Firefly Dx against measles, respiratory diseases, and Arboviral diseases. Because the Firefly Dx instrument is a universal cartridge-based system, however, it will be able to accommodate new assays or panels very rapidly. Some examples of organisms for which we have previously developed immunoassays include anthrax, small pox, various forms of influenza, and MRSA, among many others.
Q: Investorideas.com
Can you give us an update on your M-BAND system and the status of BioWatch Generation 3?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
As you know, on January 25, 2013, the U.S. Department of Homeland Security released a draft request for proposal (“RFP”) for Stage 1 of BioWatch Generation 3. At that time it was announced that the final RFP for Stage 1 would be released in the government’s third quarter of fiscal 2013, which ends June 30th. If that timeline holds, the RFP is expected to be awarded in late 2013 and have a performance period of 18 months. We look forward to the release of the final RFP and will keep our investors informed of any updates.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. http://www.PositiveIDCorp.com
About InvestorIdeas.com:
Investorideas.com is a meeting place for investors and public companies in leading sectors? Find investing ideas in biotech and biodefense stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global exchanges.
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed May 2013 for three months: $1500 plus 50,000 144 shares .
http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com: 800 665 0411
Monday, June 3, 2013
Biodefense Stock PositiveID (OTCBB: PSID) Releases White Paper on Firefly Dx Detection System and M-BAND
Point Roberts, WA - June 3, 2013 (Investorideas.com Newswire)
Investorideas.com, a leader in sector research for independent investors
, features the recently published white paper for PositiveID
Corporation (OTCBB: PSID) and the company’s biodefense technologies.
The Company’s proprietary airborne pathogen detection system, M-BAND
(Microfluidic Bio-agent Autonomous Networked Detector), was developed under
contract with the U.S. Department of Homeland Security ("DHS") Science & Technology directorate. M-BAND continuously and autonomously analyzes air samples to detect biological threats in the form of bacteria, viruses, and toxins. The Firefly Dx handheld detection system is the Company’s next-generation technology. The Company’s technology is protected by a portfolio of over 20 key patents/patents pending.
Link to white paper /PDF http://www.investorideas.com/CO/PSID/PSID_MFS_White_Paper_Firefly_Q1_2013_FINAL.pdf
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. http://www.PositiveIDCorp.com
About InvestorIdeas.com:
Investorideas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas in biotech and biodefense stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global exchanges.
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed May 2013 for three months: $1500 plus 50,000 144 shares .
http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
CONTACT:
PositiveID Corporation
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com: 800 665 0411
(Microfluidic Bio-agent Autonomous Networked Detector), was developed under
contract with the U.S. Department of Homeland Security ("DHS") Science & Technology directorate. M-BAND continuously and autonomously analyzes air samples to detect biological threats in the form of bacteria, viruses, and toxins. The Firefly Dx handheld detection system is the Company’s next-generation technology. The Company’s technology is protected by a portfolio of over 20 key patents/patents pending.
Link to white paper /PDF http://www.investorideas.com/CO/PSID/PSID_MFS_White_Paper_Firefly_Q1_2013_FINAL.pdf
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. http://www.PositiveIDCorp.com
About InvestorIdeas.com:
Investorideas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas in biotech and biodefense stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global exchanges.
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed May 2013 for three months: $1500 plus 50,000 144 shares .
http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
CONTACT:
PositiveID Corporation
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com: 800 665 0411
Wednesday, May 29, 2013
Defense Stock Alert: Homeland Security Corporation (OTC: HSCC) Launches new Website, Rolling out New Business plan following Biometrics/Security Acquisition
WRIGHTWOOD, CA - May 29, 2013 (Investorideas.com newswire) Homeland Security Corporation (OTCMarkets:HSCC), a security technology company announced today the launch of the company's new website and logo at www.hsccsecurity.com
as part of the new business strategy following the recent acquisition
of Sense Security Technologies, a custom developer and solution provider
of integrated hardware and proprietary software in the
biometrics/security industry.
The new website now offers customers new security solutions, a more
user friendly look and feel and new informative information regarding
the new product portfolio. The website also expands on the company's
intent to enhance its presence in the medical marijuana field for
securing the process of seed to sale authentication and auditing.
The new technologies and applications target the Transportation, Pharmaceutical, Law Enforcement, Healthcare, Travel and Tourism, Time and Attendance, Access Control, and Medical Marijuana Industries, including various State marijuana security/compliance markets. The HSCC website also includes all the video surveillance, camera, and security technologies that Homeland Security Corporation has offered for years.
Recently appointed President, Mr. Dore Perler said, "Our new website now encompasses all the solutions that HSCC offers in a easy manageable and simple to navigate package. " The company is prepared to add additional customers and revenues as our goal for 2013" add Mr Perler.
About Homeland Security Corporation
HSC is a leading innovator, consultant and implementer of security driven technologies that can be deployed in any environment to meet a client's security or regulatory needs. Our primary mission is to protect people, property, infrastructure, and our clients' high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies.
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
Investor relations Contact:
Darren Bankston
404-313-2198
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
The new technologies and applications target the Transportation, Pharmaceutical, Law Enforcement, Healthcare, Travel and Tourism, Time and Attendance, Access Control, and Medical Marijuana Industries, including various State marijuana security/compliance markets. The HSCC website also includes all the video surveillance, camera, and security technologies that Homeland Security Corporation has offered for years.
Recently appointed President, Mr. Dore Perler said, "Our new website now encompasses all the solutions that HSCC offers in a easy manageable and simple to navigate package. " The company is prepared to add additional customers and revenues as our goal for 2013" add Mr Perler.
About Homeland Security Corporation
HSC is a leading innovator, consultant and implementer of security driven technologies that can be deployed in any environment to meet a client's security or regulatory needs. Our primary mission is to protect people, property, infrastructure, and our clients' high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies.
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
Investor relations Contact:
Darren Bankston
404-313-2198
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Tuesday, May 14, 2013
Biometrics Stock Alert: Homeland Security Corporation (OTC: HSCC) Acquires Security and Biometric Assets and Solutions
WRIGHTWOOD, CA - May 14, 2013 (Investorideas.com newswire) Homeland Security Corporation (OTCMarkets:HSCC),
a security technology company announced today the acquisition of all
the security and biometric assets of Sense Security Technologies. Sense
Technologies is a custom developer and solution provider of integrated
hardware and proprietary software targeting the Transportation,
Pharmaceutical, Law Enforcement, Healthcare, Travel and Tourism, Time
and Attendance, Access Control, and Medical Marijuana Industries,
including various State marijuana security/compliance markets.
On March 18th the company announced it had formed a joint venture
with Sense Technologies for the development, sale and support of
additional identification methods, including Biometrics and Access
control solutions to HSCC's existing product line. The company has now
formalized this joint venture into an acquisition, using shares/equity
to complete the transaction.
The assets of Sense Security Technologies will now allow HSCC to enter the law enforcement, Time and Attendance, Access Control, and multiple other markets using biometric and card based technologies, including the Medical Marijuana industry for the development of security enhanced vending devices.
The assets specifically will include the following applications and technologies: Biometrics – fingerprint, IRIS, facial, Access control – fingerprint, IRIS, smartcard, mag, proximity card, Time and attendance – card or biometrics and Perimeter security – RFID.
Additionally HSCC has acquired all of the source code, documentation, customer base, industry contacts and suppliers.
Recently appointed President, Mr. Dore Perler said, "With the transition of the joint venture to an acquisition within the company, the company now has diverse base of assets within the security sector. We are now confident moving forward we can execute our new plan to become a competitor within the security sector."
About Homeland Security Corporation
HSC is a leading innovator, consultant and implementer of security driven technologies that can be deployed in any environment to meet a client's security or regulatory needs. Our primary mission is to protect people, property, infrastructure, and our clients' high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies.
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
http://www.homelandsecuritycorporation.com/
Please note the current website is under development
Investor relations Contact:
Darren Bankston
404-313-2198
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
The assets of Sense Security Technologies will now allow HSCC to enter the law enforcement, Time and Attendance, Access Control, and multiple other markets using biometric and card based technologies, including the Medical Marijuana industry for the development of security enhanced vending devices.
The assets specifically will include the following applications and technologies: Biometrics – fingerprint, IRIS, facial, Access control – fingerprint, IRIS, smartcard, mag, proximity card, Time and attendance – card or biometrics and Perimeter security – RFID.
Additionally HSCC has acquired all of the source code, documentation, customer base, industry contacts and suppliers.
Recently appointed President, Mr. Dore Perler said, "With the transition of the joint venture to an acquisition within the company, the company now has diverse base of assets within the security sector. We are now confident moving forward we can execute our new plan to become a competitor within the security sector."
About Homeland Security Corporation
HSC is a leading innovator, consultant and implementer of security driven technologies that can be deployed in any environment to meet a client's security or regulatory needs. Our primary mission is to protect people, property, infrastructure, and our clients' high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies.
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
http://www.homelandsecuritycorporation.com/
Please note the current website is under development
Investor relations Contact:
Darren Bankston
404-313-2198
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Thursday, May 9, 2013
Homeland Security Stock, Homeland Security Corporation (OTC Markets: HSCC) Appoints New President with Biometrics and Access Control Solutions Expertise and Contacts
WRIGHTWOOD, CA - May 9, 2013 (Investorideas.com newswire) Homeland Security Corporation (OTCBB: HSCC),
a security technology company reports the appointment of Mr. Dore
Perler as the Company's new president, in charge of day to day
operations. Mr. Perler brings over twenty years of industry experience
and contacts to the company, from both public markets and the security
sector.
Mr. Perler has a previous background as the CEO of a publicly
traded company in Biometrics, Explosive Detection technologies and
Access control solutions markets.
His extensive public company management experience includes International mergers and acquisitions, creation of financial management strategies, capital management and capital raises.
Mr. Perler will be reporting to David Shade, CEO and Chairman, to execute the new business strategy which includes building upon the security solutions division and the recently announced expansion in the Marijuana (both Medical Marijuana-MMJ and Marijuana-MJ) marketplace providing services ranging from legal and regulatory compliance to security surveillance.
Mr. Perler said, "It's one of my primary goals to take the company through the required steps and become compliant with regulatory bodies and become a fully reporting and funded entity. In parallel we are rebranding the company with a new website, new corporate identity and new plan to become a competitor in the security sector."
About Homeland Security Corporation
HSC is a leading innovator, consultant and implementer of security driven technologies that can be deployed in any environment to meet a client's security or regulatory needs. Our primary mission is to protect people, property, infrastructure, and our clients' high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies.
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
http://www.homelandsecuritycorporation.com/
Please note the current website is under development
Investor relations Contact:
Darren Bankston
404-313-2198
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
His extensive public company management experience includes International mergers and acquisitions, creation of financial management strategies, capital management and capital raises.
Mr. Perler will be reporting to David Shade, CEO and Chairman, to execute the new business strategy which includes building upon the security solutions division and the recently announced expansion in the Marijuana (both Medical Marijuana-MMJ and Marijuana-MJ) marketplace providing services ranging from legal and regulatory compliance to security surveillance.
Mr. Perler said, "It's one of my primary goals to take the company through the required steps and become compliant with regulatory bodies and become a fully reporting and funded entity. In parallel we are rebranding the company with a new website, new corporate identity and new plan to become a competitor in the security sector."
About Homeland Security Corporation
HSC is a leading innovator, consultant and implementer of security driven technologies that can be deployed in any environment to meet a client's security or regulatory needs. Our primary mission is to protect people, property, infrastructure, and our clients' high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies.
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
http://www.homelandsecuritycorporation.com/
Please note the current website is under development
Investor relations Contact:
Darren Bankston
404-313-2198
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Monday, April 22, 2013
www.investorideas.com defense stocks blog- Homeland Security news
www.investorideas.com defense stocks blog- Homeland Security news
Two men arrested and charged Monday were part of an al Qaeda-supported plot to derail a passenger train, the Royal Canadian Mounted Police said.
The suspects, Chiheb Esseghaier and Raed Jaser, are accused of conspiring to kill people on a VIA train, police said. Officials said that the suspects had the capacity to carry out an attack but that the public was never in imminent danger.
The two men were receiving support "in the form of direction and guidance" from al Qaeda elements in Iran, police said. They are not Canadian citizens.
Follow complete coverage of breaking news on CNN TV, http://cnn.com and CNN Mobile.
Published at (www.investorideas.com defense stocks blog ) Research defense and Homeland Security stocks with the largest global defense stocks directory online for investors at Investorideas.com and www.Homelanddefensestocks.com click here: http://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp Defense and security companies - Become a showcase defense stock at www.investorideas.com and www.homelanddefensestocks.com for as little as $1000 month
Two men arrested and charged Monday were part of an al Qaeda-supported plot to derail a passenger train, the Royal Canadian Mounted Police said.
The suspects, Chiheb Esseghaier and Raed Jaser, are accused of conspiring to kill people on a VIA train, police said. Officials said that the suspects had the capacity to carry out an attack but that the public was never in imminent danger.
The two men were receiving support "in the form of direction and guidance" from al Qaeda elements in Iran, police said. They are not Canadian citizens.
Follow complete coverage of breaking news on CNN TV, http://cnn.com and CNN Mobile.
Published at (www.investorideas.com defense stocks blog ) Research defense and Homeland Security stocks with the largest global defense stocks directory online for investors at Investorideas.com and www.Homelanddefensestocks.com click here: http://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp Defense and security companies - Become a showcase defense stock at www.investorideas.com and www.homelanddefensestocks.com for as little as $1000 month
Thursday, April 18, 2013
Medical Technology Breaking News: Aethlon Medical (OTCBB:AEMD) Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
SAN DIEGO - April 18, 2013 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD),
disclosed that a poster presentation entitled: "Extracorporeal Exosome
Removal: A Therapeutic Strategy to Address an Evolutionary Survival
Mechanism Shared by Cancer and Infectious Viral Pathogens," is being
presented today at the International Society of Extracellular Vesicles
(ISEV) 2013 conference being held in Boston, MA. Dr. Annette Marleau,
Director of Tumor Immunology at Aethlon Medical will give the
presentation. Information related to ISEV 2013 can be accessed online
at: www.isevmeeting.org
The Aethlon presentation discusses the specificity of the Aethlon
Hemopurifier® to address evolved glycopathogen targets that are
instrumental in cancer and infectious disease progression. Significant
points addressed in the presentation include emerging knowledge of
exosome secretion, which is a notable feature of malignancy owing to the
diverse roles of these particles in tumor-mediated immune suppression,
angiogenesis, metastasis, and resistance to therapeutic agents. As
cancer-secreted exosomes remain a critical target not addressed by drug
therapies, the Company is expanding the potential utility of the
Hemopurifier® to include cancer. In this role, the Hemopurifier®
provides an adjuvant strategy to improve current and emerging cancer
treatment outcomes without adding drug toxicity. To date, pre-clinical
Hemopurifier® studies have validated the capture of exosomes underlying
breast cancer, metastatic melanoma, ovarian cancer, lymphoma, and
colorectal cancer.
The Aethlon Hemopurifier® consists of the lectin Galanthus nivalis agglutinin (GNA) immobilized in the outer-capillary space of a plasma membrane device that is compatible for use with standard CRRT and dialysis units. GNA-based capture is mediated by unique high mannose signatures abundant on the surface of cancer-secreted exosomes as well as glycoproteins that reside on the outer membrane of infectious viral pathogens.
In human studies of treatment naive HIV and Hepatitis-C (HCV) infected individuals, Hemopurifier® therapy demonstrated average viral load reductions of greater than 50% during single four-hour treatment applications. A three-treatment Hemopurifier® protocol combined with interferon-based standard-of-care resulted in undetectable HCV in as little as seven days in hard-to-treat genotype-1 patients. In this same clinical program, post-treatment elution studies documented the capture of up to 300 billion HCV copies by the Hemopurifier® during a single six-hour treatment. A human feasibility study to initiate HCV human studies in the United States is pending IDE approval by the U.S. Food and Drug Administration (FDA).
Based on human treatment experience and exosome capture validations, the Company has identified candidate research centers to conduct a Hemopurifier® therapy study in cancer patients.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About The Aethlon Hemopurifier®
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system. In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy. In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment. Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India. The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens. The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA.
The Aethlon Hemopurifier® and Cancer
In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the development of drug resistance. By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com Newswire
More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/
Disclaimer: Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. If you have any questions regarding information in this press release please contact the company listed in the press release. Aethlon Medical, Inc. is currently an annual news release client at Investorideas.com and compensates Investorideas.com $2425 quarterly to publish and distribute news with Investorideas and its syndication partners
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
The Aethlon Hemopurifier® consists of the lectin Galanthus nivalis agglutinin (GNA) immobilized in the outer-capillary space of a plasma membrane device that is compatible for use with standard CRRT and dialysis units. GNA-based capture is mediated by unique high mannose signatures abundant on the surface of cancer-secreted exosomes as well as glycoproteins that reside on the outer membrane of infectious viral pathogens.
In human studies of treatment naive HIV and Hepatitis-C (HCV) infected individuals, Hemopurifier® therapy demonstrated average viral load reductions of greater than 50% during single four-hour treatment applications. A three-treatment Hemopurifier® protocol combined with interferon-based standard-of-care resulted in undetectable HCV in as little as seven days in hard-to-treat genotype-1 patients. In this same clinical program, post-treatment elution studies documented the capture of up to 300 billion HCV copies by the Hemopurifier® during a single six-hour treatment. A human feasibility study to initiate HCV human studies in the United States is pending IDE approval by the U.S. Food and Drug Administration (FDA).
Based on human treatment experience and exosome capture validations, the Company has identified candidate research centers to conduct a Hemopurifier® therapy study in cancer patients.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About The Aethlon Hemopurifier®
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system. In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy. In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment. Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India. The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens. The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA.
The Aethlon Hemopurifier® and Cancer
In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the development of drug resistance. By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com Newswire
More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/
Disclaimer: Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. If you have any questions regarding information in this press release please contact the company listed in the press release. Aethlon Medical, Inc. is currently an annual news release client at Investorideas.com and compensates Investorideas.com $2425 quarterly to publish and distribute news with Investorideas and its syndication partners
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Wednesday, April 17, 2013
Homeland Security Stock, Homeland Security Corporation (OTC Markets: HSCC) Reports Alliance with Sense Technologies to Integrate Identification and Access Control Into Multiple Security Applications
WRIGHTWOOD, CA - April 16, 2013 (Investorideas.com newswire) Homeland Security Corporation (PINKSHEETS: HSCC)
reported earlier in March that the company has formed a joint venture
with Sense Technologies for the development, sale and support of
additional identification methods, including Biometrics and Access
control solutions to HSCC's existing product line. Sense Technologies is
a custom developer and solution provider of integrated hardware and
proprietary software targeting the Transportation, Pharmaceutical, Law
Enforcement, Healthcare, Travel and Tourism, Time and Attendance and
Access Control industries.
HSCC and Sense have formed an alliance to co-develop multiple
security applications using HSCC surveillance and CCTV technologies with
Biometric and access control solutions to positively identify all users
accessing the system. The venture will add the most important layer of
security which is to make sure an authorized individual is the one
accessing the system or in some cases a machine. Combined with the
products HSCC distributes and has developed, the result is a totally
secure system with a complete "Audit" trail from start to finish. Sense
website can be viewed at www.senseme.com.
The company plans to target existing and new clients and industries with newly developed systems. The Sense Frontend and Backend system has the ability to integrate with any biometric, including Iris, Face, Fingerprint, and Voice depending on the application required. The systems have been designed to positively identify an authorized user and grant access, allow entry or "dispense" a product based on the user's level of authorization or license.
"We are excited to partner with Sense to bring real life positive identification to our existing security solutions. This partnership will create a much needed 'Revenue Stream' and allow the company to enter and expand new markets with complete turnkey solutions," stated David Shade, CEO of Homeland Security Corporation.
About HSCC
Homeland Security Corporation - Security and Surveillance, Biometrics and Access Control Solutions, Legal, Regulatory compliance & Security Surveillance in Marijuana Markets
Homeland Security Corporation (OTC:HSCC.PK), is a leading innovator, consultant and implementer of advanced security driven technologies that can be deployed in any environment to meet a clients security or regulatory needs. The company has been in the security product and installation business since 2001. http://www.hscsurveillance.com/
Investor info and financials
http://www.homelandsecuritycorporation.com/investors/
Biometrics and Access Control Solutions
http://www.senseme.com/
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
Contact:
Homeland Security Corporation
David L. Shade
877-931-1999
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
The company plans to target existing and new clients and industries with newly developed systems. The Sense Frontend and Backend system has the ability to integrate with any biometric, including Iris, Face, Fingerprint, and Voice depending on the application required. The systems have been designed to positively identify an authorized user and grant access, allow entry or "dispense" a product based on the user's level of authorization or license.
"We are excited to partner with Sense to bring real life positive identification to our existing security solutions. This partnership will create a much needed 'Revenue Stream' and allow the company to enter and expand new markets with complete turnkey solutions," stated David Shade, CEO of Homeland Security Corporation.
About HSCC
Homeland Security Corporation - Security and Surveillance, Biometrics and Access Control Solutions, Legal, Regulatory compliance & Security Surveillance in Marijuana Markets
Homeland Security Corporation (OTC:HSCC.PK), is a leading innovator, consultant and implementer of advanced security driven technologies that can be deployed in any environment to meet a clients security or regulatory needs. The company has been in the security product and installation business since 2001. http://www.hscsurveillance.com/
Investor info and financials
http://www.homelandsecuritycorporation.com/investors/
Biometrics and Access Control Solutions
http://www.senseme.com/
SAFE HARBOR
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, along with statements regarding Homeland's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those anticipated.
Contact:
Homeland Security Corporation
David L. Shade
877-931-1999
Published at Investorideas.com Newswire
More info on HSCC at Investorideas.com Visit: http://www.investorideas.com/CO/HSCC/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investment involves risk and loss of investment. Disclosure: HSCC has compensated investorideas.com the equivalent of $ten thousand per month in 144 shares for publishing news and content. Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp HSCC is not a fully reporting company. More info can be viewed at otcmarkets.com and the company websites.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Biodefense Stock Alert; Aethlon Medical (OTCBB: AEMD) Moves Following News on Contract
Point Roberts, WA - April 17, 2013 (Investorideas.com newswire) -
Investorideas.com, an investor research portal specializing in sector
research for independent investors including biodefense and homeland
security stocks issues a trading alert for Aethlon Medical, Inc. (OTCBB: AEMD), trading at $0.1099, up 0.0070 6.80% 12:43PM EDT on over 688,000 shares. The stock had a morning high of $0.12.
The company reported yesterday it entered into a subcontract
agreement with Battelle Memorial Institute (Battelle) to provide
services underlying a $22.8 million prime contract that was recently
awarded to Battelle by the Defense Advanced Research Projects Agency
(DARPA).
According to the press release, "The objective of this contract program is to integrate component technologies developed in DARPA's Dialysis Like Therapeutics (DLT) program into medical device that would save military and civilian lives by effectively treating sepsis. Beyond expanding our opportunity in the DLT program, we are honored to have the opportunity to work with Battelle (the world's largest independent research and development organization) on this endeavor."
The Company's Chairman and CEO also went on to say, "I am pleased to report that the funding spigot for countermeasures against bioterror and pandemic threats has been turned back on. Last month, The Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 was signed into law by President Obama. The law reauthorizes provisions of the Project Bioshield Act of 2004 and extends the mandate of the Biomedical Advanced Research and Development Authority (BARDA) to support medical countermeasure development for biothreat agents for possible inclusion in the U.S. Strategic National Stockpile. PAHPRA also enhances the authority of the FDA to support rapid responses to public health emergencies by clarifying that even before an event occurs, FDA may issue an emergency use authorization to allow emergency use of certain products as medical countermeasures. The Congressional Budget Office estimates that $11 billion will be spent on PAHPRA between fiscal years 2014 to 2018."
Full news: http://finance.yahoo.com/news/aethlon-medical-aemd-note-government-133000119.html
More info on AEMD: http://www.investorideas.com/CO/AEMD/
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free news and stock alerts including biotech and biodefense stocks http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - biotech and life sciences, biodefense and homeland security , water, renewable energy, mining stocks http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: AEMD is a paid client for news release and content distribution on the investorideas.com newswire and syndication partners (annual fee program 9700)
http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
According to the press release, "The objective of this contract program is to integrate component technologies developed in DARPA's Dialysis Like Therapeutics (DLT) program into medical device that would save military and civilian lives by effectively treating sepsis. Beyond expanding our opportunity in the DLT program, we are honored to have the opportunity to work with Battelle (the world's largest independent research and development organization) on this endeavor."
The Company's Chairman and CEO also went on to say, "I am pleased to report that the funding spigot for countermeasures against bioterror and pandemic threats has been turned back on. Last month, The Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 was signed into law by President Obama. The law reauthorizes provisions of the Project Bioshield Act of 2004 and extends the mandate of the Biomedical Advanced Research and Development Authority (BARDA) to support medical countermeasure development for biothreat agents for possible inclusion in the U.S. Strategic National Stockpile. PAHPRA also enhances the authority of the FDA to support rapid responses to public health emergencies by clarifying that even before an event occurs, FDA may issue an emergency use authorization to allow emergency use of certain products as medical countermeasures. The Congressional Budget Office estimates that $11 billion will be spent on PAHPRA between fiscal years 2014 to 2018."
Full news: http://finance.yahoo.com/news/aethlon-medical-aemd-note-government-133000119.html
More info on AEMD: http://www.investorideas.com/CO/AEMD/About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free news and stock alerts including biotech and biodefense stocks http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - biotech and life sciences, biodefense and homeland security , water, renewable energy, mining stocks http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: AEMD is a paid client for news release and content distribution on the investorideas.com newswire and syndication partners (annual fee program 9700)
http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
Monday, April 1, 2013
Homeland Security –Defense site for sale
Homeland Security –Defense site for sale
Investorideas.com has the following website for sale
National Homeland Security Knowledgebase.com
call 800 665 0411
or Dvanzant@investorideas..com
About InvestorIdeas.com: Investor Ideas for global investors; invest in what you like!
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on TSX, OTC, NASDAQ and global exchanges.
The Investor Ideas newswire is a news source on Google news, Google Currents and Linkedin.com/Today news. Investorideas.com newswire is now available as a free mobile app for iPhone orAndroid. Go here or here for link
Follow Investorideas.com on Twitter
Follow Investorideas.com on Facebook
Follow Investorideas.com News on Linkedin.com/today
Sign up for free stock alerts at Investorideas.com
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Thursday, March 21, 2013
Q&A Interview with Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS) Discussing Sequestration and its impact on the Defense sector and Defense Stocks
Q&A Interview with Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS) Discussing Sequestration and its impact on the Defense sector and Defense Stocks
Point Roberts WA- March 11, 2013 (www.investorideas.com newswire, www.homelanddefensestocks.com ) Investorideas.com, an investor research portal specializing in sector research including defense and Homeland Defense stocks issues a recent interview with Mr. Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS), the underlying index for the Powershares Aerospace & Defense ETF (NYSE: PPA).
Scott Sacknoff discusses his impressions on the sequestration and its impact on the defense sector and defense stocks.
Q: Investorideas.com
Mr. Sacknoff, several months ago you mentioned that until the sequestration was resolved you planned to be pretty quiet, why is that?
A: Sacknoff: That’s true. Last year I said that until all the sequestration and budget issues were resolved, how defense stocks would response was just a guess. Calling a bottom without knowing where cuts were going to come from, which programs would be impacted, and as importantly, when they’d be impacted makes evaluating companies and stocks more difficult that normal. That said, there were a number of strengths in the sector – international exports, growth in commercial aerospace, cybersecurity, and great balance sheets with tremendous cash positions and I thought these factors would offset the flattening and declines in the defense budget. But sequestration was a wild card. Recognizing the stabilizing factors means little when the government throws a monkey wrench into your calculations. So instead of guessing, putting out an opinion didn’t seem right.
Q: Investorideas.com
So, sequestration took effect. Were you surprised that Congress didn’t fix the issue?
A: Sacknoff: Not really. I thought it was a horrible idea and its execution will cause lots of problems whose impact won’t be felt for months, but nothing Congress does (or doesn’t do) really surprises me anymore. Democrats thought he Republicans would budget and they called that bluff and decided enacting budget cuts were more important than supporting the defense sector.
Q: Investorideas.com
And what did happen in the market?
A: Sacknoff: Well, despite constant media attention on the fiscal cliff and sequestration the SPADE Defense Index (NYSE: DXS) managed to outperform the broader market, gaining 16.3% in 2012. And it’s up 5% more to start 2013, 52-week highs. So those that said, they will ride it out and collect the dividends, which for the Powershares Aerospace & Defense ETF was a bit above 2.0% according to Yahoo, they were happy they chose that path. Still, the market reaction instead of ignoring sequestration could have focused on the impact and drop in GDP and stocks could have easily have fallen. There was something else I did find unusual.
Q: Investorideas.com
What was that?
A: Sacknoff: Well, I believe that in an unknown environment, owning a fund for diversifications reasons instead of holding an individual stock makes sense; especially if you are unsure which companies would be impacted the most. Yet over the past several months, the opposite appears to have happened. As the stocks, and of course the funds, moved higher, so people were obviously buying the sector, the number of shares held in the various funds declined. It’s a shame because when you compare the performance of companies such as Lockheed Martin (NYSE: LMT) and Boeing (NYSE: BA) with the Powershares Aerospace & Defense ETF (NYSE: PPA) for example, and investors would have benefited from being invested in the fund.
Q: Investorideas.com
So, where do you think things are headed from here?
A: Sacknoff: There is still a fair amount of unknowns however some things to keep in mind. A Continuing Resolution to fund the government at 2012 levels through September is currently being debated. This would provide DoD with $518 billion in nonwar funding plus an additional $87 billion for overseas war-on-terror activities.
Now, many people outside Washington would think is a good thing, yet the problem with a CR is that not only do the budget numbers remain fixed but what their spent on is fixed as well. Picture if you budgeted $20,000 for a new car in 2012 and being told ‘here’s another $20,000 to spend for a car in 2013’ even though you didn’t need one and would rather spend the money on fixing your heating system. It does appear though that Congress will give the Pentagon some flexibility to allocate funds with some limited flexibility. Investors should keep in mind though that anticipated defense spending reductions over the next several years will take us, roughly, to the levels seen in 2007, levels much higher than after 9/11, near the beginning of the last defense spending build-up.
Also, sequestration reductions won’t mean the canceling of previously awarded contracts and the agency is going to find as many non-essential areas to cut as possible. The first cuts announced will be closing the military’s worldwide commissary network one extra day each week and issuing partial furloughs to 15,000 military school teachers and staff. So, for at least the moment, the impact on public defense stocks is delayed.
Q. Investorideas.com
Lastly, what do you think the play is for 2013?
A: Sacknoff: Personally, I’d expect aerospace suppliers to produce solid gains and for Boeing to rebound from 2012’s market underperformance once the issues with the 787 batteries are resolved. And I see C4ISR and cybersecurity firms gaining traction in spite of the budget issues at DoD as IT companies such as SAIC, CACI, KEYW, etc gain customers from other government agencies and increasingly from private firms wanting DoD-level security to protect their networks. With cyber attacks up 44% and 75 million pieces of malware on the net, even the banking community has turned to the National Security Agency for advice.
Investorideas.com
This has been great. Thank you for making the time to chat today.
Sacknoff: My pleasure.
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors . Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks , oil and gas , water stocks , renewable energy, beverage stocks, defense stocks, nanotech and more . The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Or …
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors including defense stocks, oil and gas stocks, mining …
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products
http://www.investorideas.com/About/Disclaimer.asp
or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Point Roberts WA- March 11, 2013 (www.investorideas.com newswire, www.homelanddefensestocks.com ) Investorideas.com, an investor research portal specializing in sector research including defense and Homeland Defense stocks issues a recent interview with Mr. Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS), the underlying index for the Powershares Aerospace & Defense ETF (NYSE: PPA).
Scott Sacknoff discusses his impressions on the sequestration and its impact on the defense sector and defense stocks.
Q: Investorideas.com
Mr. Sacknoff, several months ago you mentioned that until the sequestration was resolved you planned to be pretty quiet, why is that?
A: Sacknoff: That’s true. Last year I said that until all the sequestration and budget issues were resolved, how defense stocks would response was just a guess. Calling a bottom without knowing where cuts were going to come from, which programs would be impacted, and as importantly, when they’d be impacted makes evaluating companies and stocks more difficult that normal. That said, there were a number of strengths in the sector – international exports, growth in commercial aerospace, cybersecurity, and great balance sheets with tremendous cash positions and I thought these factors would offset the flattening and declines in the defense budget. But sequestration was a wild card. Recognizing the stabilizing factors means little when the government throws a monkey wrench into your calculations. So instead of guessing, putting out an opinion didn’t seem right.
Q: Investorideas.com
So, sequestration took effect. Were you surprised that Congress didn’t fix the issue?
A: Sacknoff: Not really. I thought it was a horrible idea and its execution will cause lots of problems whose impact won’t be felt for months, but nothing Congress does (or doesn’t do) really surprises me anymore. Democrats thought he Republicans would budget and they called that bluff and decided enacting budget cuts were more important than supporting the defense sector.
Q: Investorideas.com
And what did happen in the market?
A: Sacknoff: Well, despite constant media attention on the fiscal cliff and sequestration the SPADE Defense Index (NYSE: DXS) managed to outperform the broader market, gaining 16.3% in 2012. And it’s up 5% more to start 2013, 52-week highs. So those that said, they will ride it out and collect the dividends, which for the Powershares Aerospace & Defense ETF was a bit above 2.0% according to Yahoo, they were happy they chose that path. Still, the market reaction instead of ignoring sequestration could have focused on the impact and drop in GDP and stocks could have easily have fallen. There was something else I did find unusual.
Q: Investorideas.com
What was that?
A: Sacknoff: Well, I believe that in an unknown environment, owning a fund for diversifications reasons instead of holding an individual stock makes sense; especially if you are unsure which companies would be impacted the most. Yet over the past several months, the opposite appears to have happened. As the stocks, and of course the funds, moved higher, so people were obviously buying the sector, the number of shares held in the various funds declined. It’s a shame because when you compare the performance of companies such as Lockheed Martin (NYSE: LMT) and Boeing (NYSE: BA) with the Powershares Aerospace & Defense ETF (NYSE: PPA) for example, and investors would have benefited from being invested in the fund.
Q: Investorideas.com
So, where do you think things are headed from here?
A: Sacknoff: There is still a fair amount of unknowns however some things to keep in mind. A Continuing Resolution to fund the government at 2012 levels through September is currently being debated. This would provide DoD with $518 billion in nonwar funding plus an additional $87 billion for overseas war-on-terror activities.
Now, many people outside Washington would think is a good thing, yet the problem with a CR is that not only do the budget numbers remain fixed but what their spent on is fixed as well. Picture if you budgeted $20,000 for a new car in 2012 and being told ‘here’s another $20,000 to spend for a car in 2013’ even though you didn’t need one and would rather spend the money on fixing your heating system. It does appear though that Congress will give the Pentagon some flexibility to allocate funds with some limited flexibility. Investors should keep in mind though that anticipated defense spending reductions over the next several years will take us, roughly, to the levels seen in 2007, levels much higher than after 9/11, near the beginning of the last defense spending build-up.
Also, sequestration reductions won’t mean the canceling of previously awarded contracts and the agency is going to find as many non-essential areas to cut as possible. The first cuts announced will be closing the military’s worldwide commissary network one extra day each week and issuing partial furloughs to 15,000 military school teachers and staff. So, for at least the moment, the impact on public defense stocks is delayed.
Q. Investorideas.com
Lastly, what do you think the play is for 2013?
A: Sacknoff: Personally, I’d expect aerospace suppliers to produce solid gains and for Boeing to rebound from 2012’s market underperformance once the issues with the 787 batteries are resolved. And I see C4ISR and cybersecurity firms gaining traction in spite of the budget issues at DoD as IT companies such as SAIC, CACI, KEYW, etc gain customers from other government agencies and increasingly from private firms wanting DoD-level security to protect their networks. With cyber attacks up 44% and 75 million pieces of malware on the net, even the banking community has turned to the National Security Agency for advice.
Investorideas.com
This has been great. Thank you for making the time to chat today.
Sacknoff: My pleasure.
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors . Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks , oil and gas , water stocks , renewable energy, beverage stocks, defense stocks, nanotech and more . The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Or …
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors including defense stocks, oil and gas stocks, mining …
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products
http://www.investorideas.com/About/Disclaimer.asp
or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Wednesday, March 13, 2013
Defense and Security Investor Ideas: A year of sector stock research for just $67
March 13, 2013 (www.investorideas.com newswire)
www.InvestorIdeas.com, a global investor research portal for independent
investors, announces a special limited time offer on its annual
membership program, discounted from its previous price, to allow
investors that have missed the current market rally to invest and
research their favorite sector.
Members can login to access 14 global stock directories covering
water stocks, renewable energy stocks, oil and gas stocks, biotech
stocks, gold-mining stocks, nanotech stocks, Mobile stocks, Social
Networking and Cloud Computing Stocks, defense stocks, beverage stocks
and more! Directories include stocks on the TSX, OTC, PINK, NASDAQ,
Frankfurt, AIM, ASX, Hong Kong Exchange and major exchanges.
Investorideas.com stock directories are the most comprehensive online and are used by institutional investors as well as retail investors.
Directories are updated each month as new IPO's come to market in leading sectors.
From now until Friday investors can get the Investorideas.com annual membership for just $67 - discounted from its regular $97 price.
Directories are also sold individually in a clickable PDF format.
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors . Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks , oil and gas , water stocks , renewable energy, beverage stocks, defense stocks, nanotech and more . The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products
http://www.investorideas.com/About/Disclaimer.asp
or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
Investorideas.com stock directories are the most comprehensive online and are used by institutional investors as well as retail investors.
Directories are updated each month as new IPO's come to market in leading sectors.
From now until Friday investors can get the Investorideas.com annual membership for just $67 - discounted from its regular $97 price.
Directories are also sold individually in a clickable PDF format.
Join Investor Ideas - Become a Member for just $67
Expires 3:00 PM EST March 15th
http://www.investorideas.com/membership/On-Sale.asp
About InvestorIdeas.com:Expires 3:00 PM EST March 15th
http://www.investorideas.com/membership/On-Sale.asp
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors . Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks , oil and gas , water stocks , renewable energy, beverage stocks, defense stocks, nanotech and more . The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products
http://www.investorideas.com/About/Disclaimer.asp
or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
Monday, March 11, 2013
Q&A Interview with Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS) Discussing Sequestration and its impact on the Defense sector and Defense Stocks
Q&A Interview with Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS) Discussing Sequestration and its impact on the Defense sector and Defense Stocks
Point Roberts WA- March 11, 2013 (www.investorideas.com newswire, www.homelanddefensestocks.com ) Investorideas.com, an investor research portal specializing in sector research including defense and Homeland Defense stocks issues a recent interview with Mr. Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS), the underlying index for the Powershares Aerospace & Defense ETF (NYSE: PPA).
Scott Sacknoff discusses his impressions on the sequestration and its impact on the defense sector and defense stocks.
Q: Investorideas.com
Mr. Sacknoff, several months ago you mentioned that until the sequestration was resolved you planned to be pretty quiet, why is that?
A: Sacknoff: That’s true. Last year I said that until all the sequestration and budget issues were resolved, how defense stocks would response was just a guess. Calling a bottom without knowing where cuts were going to come from, which programs would be impacted, and as importantly, when they’d be impacted makes evaluating companies and stocks more difficult that normal. That said, there were a number of strengths in the sector – international exports, growth in commercial aerospace, cybersecurity, and great balance sheets with tremendous cash positions and I thought these factors would offset the flattening and declines in the defense budget. But sequestration was a wild card. Recognizing the stabilizing factors means little when the government throws a monkey wrench into your calculations. So instead of guessing, putting out an opinion didn’t seem right.
Q: Investorideas.com
So, sequestration took effect. Were you surprised that Congress didn’t fix the issue?
A: Sacknoff: Not really. I thought it was a horrible idea and its execution will cause lots of problems whose impact won’t be felt for months, but nothing Congress does (or doesn’t do) really surprises me anymore. Democrats thought he Republicans would budget and they called that bluff and decided enacting budget cuts were more important than supporting the defense sector.
Q: Investorideas.com
And what did happen in the market?
A: Sacknoff: Well, despite constant media attention on the fiscal cliff and sequestration the SPADE Defense Index (NYSE: DXS) managed to outperform the broader market, gaining 16.3% in 2012. And it’s up 5% more to start 2013, 52-week highs. So those that said, they will ride it out and collect the dividends, which for the Powershares Aerospace & Defense ETF was a bit above 2.0% according to Yahoo, they were happy they chose that path. Still, the market reaction instead of ignoring sequestration could have focused on the impact and drop in GDP and stocks could have easily have fallen. There was something else I did find unusual.
Q: Investorideas.com
What was that?
Sacknoff: Well, I believe that in an unknown environment, owning a fund for diversifications reasons instead of holding an individual stock makes sense; especially if you are unsure which companies would be impacted the most. Yet over the past several months, the opposite appears to have happened. As the stocks, and of course the funds, moved higher, so people were obviously buying the sector, the number of shares held in the various funds declined. It’s a shame because when you compare the performance of companies such as Lockheed Martin (NYSE: LMT) and Boeing (NYSE: BA) with the Powershares Aerospace & Defense ETF (NYSE: PPA) for example, and investors would have benefited from being invested in the fund.
Q: Investorideas.com
So, where do you think things are headed from here?
A: Sacknoff: There is still a fair amount of unknowns however some things to keep in mind. A Continuing Resolution to fund the government at 2012 levels through September is currently being debated. This would provide DoD with $518 billion in nonwar funding plus an additional $87 billion for overseas war-on-terror activities.
Now, many people outside Washington would think is a good thing, yet the problem with a CR is that not only do the budget numbers remain fixed but what their spent on is fixed as well. Picture if you budgeted $20,000 for a new car in 2012 and being told ‘here’s another $20,000 to spend for a car in 2013’ even though you didn’t need one and would rather spend the money on fixing your heating system. It does appear though that Congress will give the Pentagon some flexibility to allocate funds with some limited flexibility. Investors should keep in mind though that anticipated defense spending reductions over the next several years will take us, roughly, to the levels seen in 2007, levels much higher than after 9/11, near the beginning of the last defense spending build-up.
Also, sequestration reductions won’t mean the canceling of previously awarded contracts and the agency is going to find as many non-essential areas to cut as possible. The first cuts announced will be closing the military’s worldwide commissary network one extra day each week and issuing partial furloughs to 15,000 military school teachers and staff. So, for at least the moment, the impact on public defense stocks is delayed.
Q. Investorideas.com
Lastly, what do you think the play is for 2013?
A: Sacknoff: Personally, I’d expect aerospace suppliers to produce solid gains and for Boeing to rebound from 2012’s market underperformance once the issues with the 787 batteries are resolved. And I see C4ISR and cybersecurity firms gaining traction in spite of the budget issues at DoD as IT companies such as SAIC, CACI, KEYW, etc gain customers from other government agencies and increasingly from private firms wanting DoD-level security to protect their networks. With cyber attacks up 44% and 75 million pieces of malware on the net, even the banking community has turned to the National Security Agency for advice.
Investorideas.com
This has been great. Thank you for making the time to chat today.
Sacknoff: My pleasure.
InvestorIdeas.com is a meeting place for investors and public companies in leading sectors . Find investing ideas in biotech stocks, tech and mobile stocks, mining stocks , oil and gas , water stocks , renewable energy, beverage stocks, defense stocks, nanotech and more . The Investor Ideas newswire is a news source on Google news and Linkedin.com/Today news .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Or …
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors including defense stocks, oil and gas stocks, mining …
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products
http://www.investorideas.com/About/Disclaimer.asp
or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Subscribe to:
Posts (Atom)